Internal medicine journal
-
Internal medicine journal · May 2023
Hepatitis C virus in people with serious mental illness: An analysis of the care cascade at a tertiary health service with a pilot 'identify and treat' strategy.
People with serious mental illness (SMI) are underserved from a hepatitis C virus (HCV) screening and treatment perspective. ⋯ People with SMI are underserved by traditional models of HCV healthcare. Intensified community-based support can partially bolster the treatment cascade, although investment in innovative screening and management strategies are required to achieve healthcare parity.
-
Internal medicine journal · May 2023
Poor engagement and adherence predict neoplasia in inflammatory bowel disease: a case-control study.
Colorectal adenocarcinoma is an important and preventable complication of inflammatory bowel disease (IBD). A previous case series suggested mental health issues and poor engagement in care as novel risk factors. ⋯ This study confirms poor adherence or engagement with care as a new risk factor for colorectal adenocarcinoma in patients with IBD; identifying a vulnerable group whom clinicians should endeavour to engage in order to avoid this catastrophic complication.
-
Internal medicine journal · May 2023
Sentinel cluster of locally acquired Japanese encephalitis in southern Australia.
Prior to January 2022, only a single case of infection with Japanese encephalitis virus (JEV) had been reported on the Australian mainland, acquired in the northern extremity on Cape York. We report the clinical characteristics of the sentinel cluster of cases that confirmed the local acquisition of JEV in southern Australia along the Murray River bordering New South Wales and Victoria.
-
Internal medicine journal · May 2023
Impact of a pharmacist led thiopurine monitoring service in outpatients with inflammatory bowel disease.
Thiopurines are effective therapies for inflammatory bowel disease (IBD); however, treatment comes with safety concerns and adverse effects. Knowledge of the impact of pharmacists performing thiopurine monitoring is limited. ⋯ Pharmacist monitoring of thiopurine therapy initiation in IBD outpatients improves adverse effect monitoring and increases medication persistence.